Baby Formula Emergency Act
Summary
Baby Formula Emergency Act This bill authorizes the President, during an infant formula shortage or potential shortage, to allow the production and marketing or duty-free importation of infant formula that meets specified criteria, regardless of Food and Drug Administration (FDA) requirements. The criteria include that the United States has not imposed any sanctions with respect to the manufacturer of the formula and the FDA has not determined that such formula is unsafe. Further, the President must notify Congress about determinations related to supply shortages of infant formula.
Bill status
in committee
1 of 4 stages cleared
Introduction
May 2022
Committee Review
Floor Vote
President
Introduced May 18, 2022
Last action May 18, 2022
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
3
Key actions
0
Committee
2
May 18, 2022
Committee
Referred to the Subcommittee on Trade.
lower
May 18, 2022
Committee
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
lower
May 18, 2022
Introduced
Introduced in House
lower
1 primary · 8 co-sponsors
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 7822
Scope: US
Hi! I can help you understand HR 7822. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline